
Massimo Mantegazza
@mantegazzamassi
Pathophysiology of neuronal excitability in epilepsy, migraine and neurodevelopmental diseases.
ID: 1701860647
http://www.ipmc.cnrs.fr/?page=mantegazza&lang=uk 26-08-2013 12:43:24
30 Tweet
193 Followers
166 Following







🗓️ Next March, EnfermerasMadrid will host the European Dravet Syndrome Conference 2024 🧬🔬, an international event 🌍 for experts in #Dravet 💜. ⚠️If you are a researcher, submit your #abstract before October 15th‼ 👉 dravetconference.com 👈






New lab's paper. NaV1.1/Scn1a phenotype: homozygous patient's gain-of-function variant causes life-threatening apneas and brainstem depolarization; responds to sodium channel blockers. pnas.org/doi/10.1073/pn…. With S.Cestele, E.Tolner, Andreas Brunklaus , A.van den Maagdenberg, et al.





In the first talk of the is series Massimo Mantegazza will not only share exciting new data on Nav1.1 and its role in pathophysiology, but he will also remember Dr. Bill Catterall and his contributions to the sodium channel field. So be prepared for a special seminar next week!

After the seminar is before the seminar! Following the very successful start mark your calendars for the next #WWSCS given by Dr. Rajesh Khanna of the KhannaLabUF on Oct 29 on “The path to drugging Nav1.7: Why aren’t we there yet?" Visit sodiumchannelsemianrs.org for more info and the login link.



